作者: Bryan M. Tucker , Sami Safadi , Allon N. Friedman
DOI: 10.1053/J.JRN.2014.09.003
关键词:
摘要: Because of concern that United States (US) chronic hemodialysis patients are at high risk for the development vitamin deficiencies, great majority such routinely supplemented with a multivitamin. This policy is supported by major US dialysis providers and nonprofit organizations. Yet routine multivitamin supplementation expands patients' already large pill burden, probably accounts many millions dollars in annual costs, light previous reports may even carry it possibility increased adverse outcomes. An analysis benefits therefore order. We performed systematic review medical literature between 1970 2014 using Ovid MEDLINE database to address this question. conclude there insufficient evidence support use recommend decision supplement be made on an individual basis.